Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05241418 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Atrial Late Gadolinium Enhancement in Patients With Repaired Congenital Heart Disease

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jun 30, 2026 → Jun 30, 2027
See other at-risk trials from Boston Children's Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jun 30, 2026 to Jun 30, 2027 Show 6 more changesShow less
    • Lead sponsor: Boston Children's Hospital to Boston Children's Hospital
    • Enrollment closed, study ongoing
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site details revised
    • Publications: details revised at 9 of 9 entries
    • Eligibility criteria expanded, about 2 words
  2. Primary completion date: Jun 30, 2024 to Jun 30, 2026
    • Site contact updated
    v4
  3. Primary completion date: Jun 30, 2023 to Jun 30, 2024
    • Study completion date: Jun 30, 2028 to Jun 30, 2029
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2022 to Mar 23, 2022
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this research study the investigators want to learn more about how well the investigators can visualize scar tissue in the heart by MRI. In patients with congenital heart disease who need a procedure in the electrophysiology laboratory, how the MRI findings match the findings in the electrophysiology laboratory is not known. This study works to answer these questions. Participants will undergo a cardiac MRI as part of the routine clinical care that was ordered by their doctors and additional imaging by cardiac MRI will be performed.
Trial Details
NCT Number NCT05241418
Lead Sponsor Boston Children's Hospital
Conditions
(from sponsor)		 Congenital Heart Disease, Fibrosis Myocardial, Fibrosis; Heart
Related terms Fibrosis, Heart Defects, Congenital
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov